You are here : Home > BCI Laboratory > Identification of new therapeutic targets for kidney cancers

highlight / actuality

Identification of new therapeutic targets for kidney cancers



We demonstrate the value of using a cocktail of protein kinase inhibitors against a form of kidney cancer. For this, they assessed the impact of combination​s of molecules on the viability of kidney cancer cells grown as spheroids, or organ cultures of tumors. The synergistic benefit of two molecules allowed to file a patent.

Published on 25 January 2016
Highlight available in French.


Top page